Analyst Pin-board DBD – Nhon Hoi anti-cancer factory continues to miss out with GMP – EU standards approval plan
- By the end of the first half of 2022, DBD recorded net revenue and PBT of VND 696 billion (+16% YoY) and VND 135 billion (+17.6% YoY), completing 43% and 63% of the annual plan, respectively. The two main sales channels were ETC (hospital) and OTC (pharmacy) with positive growth, recording net revenue of VND 369 billion (+13% YoY) and VND 257 billion (+13% YoY).
- DBD has been expanding coverage in drugstores thanks to the data ownership of 40,000 pharmacies that has been standardized to build a Master Coverage Plan (MCP) for the sales team. The company pushed the number of retailers up from 14,800 in 2021 to 17,500 in 6M2022.
- The process of approving the GMP – EU standards for Nhon Hoi anti-cancer factory could not be completed with the plan because the approval of the factory abroad has not been given priority by the European health organizations. The company set new plans to achieve GMP – EU standards for the production line of injectables and pills (belonging to Nhon Hoi anti-cancer factory) in June 2023 and March 2024, respectively.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
Viet Dragon Securities belongs to top 20 biggest securities companies in terms of chartered capital in Vietnam. With a qualified, dedicated and professional team, a widespread network, advanced technology, diversified products and services, and good relationship with local and foreign institutions, we provide a wide range of services and products to our clients both individuals and institutions, both local and foreign. We commit to provide our clients with promising investment opportunities and a comprehensive and professional financial investment services.
RongViet Research reports are diversified and abundant, along with in-depth analysis and performed by experienced, highly-qualified and knowledgeable teams. With the objectives of transparency, accurate and timely manner, RongViet believes that our products would always be important sources of information for customers/investors’ investment decisions.”
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.